- Scleroderma, localized
Your QuestionI have been diagnosed with morphea. Can you please provide me with patient-friendly information about this disease?
We have identified the following information that we hope you find helpful. If you still have questions, please contact us.
Questions on this page
- What is localized scleroderma?
- What causes morphea?
- What symptoms are associated with morphea?
- How might morphea be treated?
- What is the prognosis for individuals with morphea?
- Who can I contact to learn more about morphea and other forms of localized scleroderma?
- How can I locate research for morphea?
- How can I find journal articles on morphea?
Localized scleroderma is characterized by thickening of the skin from excessive collagen deposits. Collagen is a protein normally present in our skin that provides structural support. However, when too much collagen is made, the skin becomes stiff and hard. Localized types of scleroderma are those limited to the skin and related tissues and, in some cases, the muscle below. Internal organs are not affected by localized scleroderma, and localized scleroderma can never progress to the systemic form of the disease. Often, localized conditions improve or go away on their own over time, but the skin changes and damage that occur when the disease is active can be permanent. For some people, localized scleroderma is serious and disabling.
There are two generally recognized types of localized scleroderma: morphea and linear.
Signs and symptoms of morphea, include:
- Hardening of the skin.
- Thickening of the skin.
- Discoloration of the affected skin to look lighter or darker than the surrounding area.
The first signs of the disease are reddish patches of skin that thicken into firm, oval-shaped areas. The center of each patch becomes ivory colored with violet borders. These patches sweat very little and have little hair growth. Patches appear most often on the chest, stomach, and back. Sometimes they appear on the face, arms, and legs.
Morphea usually affects only the uppermost layers of your skin, but in some cases may involve fatty or connective tissue below your skin.
Morphea can be either localized or generalized. Localized morphea limits itself to one or several patches, ranging in size from a half-inch to 12 inches in diameter. The condition sometimes appears on areas treated by radiation therapy. Some people have both morphea and linear scleroderma (which is characterized by a single line or band of thickened and/or abnormally colored skin). The disease is referred to as generalized morphea when the skin patches become very hard and dark and spread over larger areas of the body.
There is no cure for morphea. Treatment is aimed at controlling the signs and symptoms and slowing the spread of the disease. The precise treatment depends on the extent and severity of the condition.
Some people with mild morphea may choose to defer treatment. For people with morphea involving only the skin who want treatment, treatment may involve UVA1 phototherapy (or else broad band UVA, narrow band UVB, or PUVA), tacrolimus ointment, or steroid shots. Other treatment options include high potency steroid creams, vitamin D analog creams, or imiquimod. If a persons morphea is rapidly progressive, severe, or causing significant disability treatment options may include systemic steroids (glucocorticoids) and methotrexate. People with morphea should be monitored for joint changes and referred for physical and occupational therapy as appropriate.
Additionally, NIAMS offers printed materials on scleroderma. We recommend calling the toll-free number below to request a copy of this information.
National Institute of Arthritis and Musculoskeletal and Skin Diseases Information Clearinghouse
National Institutes of Health
1 AMS Circle
Bethesda, Maryland 20892-3675
Toll free: 877-22-NIAMS
Web site: http://www.niams.nih.gov/hi/index.htm
More information on scleroderma can be found at the following link from MEDLINEplus, the National Library of Medicine Web site designed to help you research your health questions.
ClinicalTrials.gov lists trials that are studying or have studied morphea. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
You can also contact the Patient Recruitment and Public Liaison (PRPL) Office at the National Institutes of Health (NIH). We recommend calling the toll-free number listed below to speak with a specialist, who can help you determine if you are eligible for any clinical trials.
Patient Recruitment and Public Liaison Office
NIH Clinical Center
Bethesda, Maryland 20892-2655
Web site: http://clinicalcenter.nih.gov/
If you are interested in enrolling in a clinical trial, you can find helpful general information on clinical trials at the following ClinicalTrials.gov Web page.
A tutorial about clinical trials that can also help answer your questions can be found at the following link from the National Library of Medicine:
Resources on many charitable or special-fare flights to research and treatment sites and low-cost hospitality accommodations for outpatients and family members, as well as ambulance services, are listed on the Web site of the Office of Rare Diseases (ORD), part of the National Institutes of Health.
- Localized Scleroderma. Scleroderma Foundation. http://www.scleroderma.org/site/DocServer/Localized.pdf?docID=317. Accessed 6/23/2011.
- . Scleroderma. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). May 2010; http://www.niams.nih.gov/Health_Info/Scleroderma/. Accessed 6/23/2011.
- Morphea. MayoClinic.com. May 6, 2010; http://www.mayoclinic.com/print/morphea/DS00718/DSECTION=all&METHOD=print. Accessed 6/23/2011.
- Jacobe H. Treatment of morphea (localized scleroderma) in adults. In: Callen J ed. UpToDate. Waltham, MA: UpToDate; Last updated May 29, 2015; Accessed 11/11/2015.